¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"diffuse interstitial pulmonary fibrosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • interstitial nucleus
    »çÀÌÁúÇÙ, °£ÁúÇÙ
  • interstitial opacity
    »çÀÌÁúȥŹ, °£ÁúȥŹ
  • interstitial pancreatitis
    »çÀÌÁúÀÌÀÚ¿°, °£ÁúÃéÀå¿°
  • interstitial plasma cell pneumonia
    »çÀÌÁúÇüÁú¼¼Æ÷Æó·Å, ÆóÆ÷ÀÚÃæÁõ
  • interstitial pneumonia
    °£ÁúÆó·Å, »çÀÌÁúÆó·Å
  • interstitial pregnancy
    »çÀÌÁúÀÓ½Å, Àڱú®ÀڱðüÀÓ½Å
  • interstitial salpingitis
    1. »çÀÌÁúÀڱðü¿°, °£Áú³­°ü¿° 2. »çÀÌÁú±Í°ü¿°, °£ÁúÀ̰ü¿°
  • interstitial tissue
    »çÀÌÁúÁ¶Á÷, °£ÁúÁ¶Á÷
  • luetic interstitial keratitis
    ¸Åµ¶»çÀÌÁú°¢¸·¿°, ¸Åµ¶°£Áú°¢¸·¿°
  • lymphoid interstitial pneumonia
    ¸²ÇÁ±¸»çÀÌÁúÆó·Å, ¸²ÇÁ±¸°£ÁúÆó·Å
  • progressive hypertrophic interstitial neuritis
    ÁøÇàºñ´ë»çÀÌÁú½Å°æ¿°, ÁøÇàºñ´ë°£Áú½Å°æ¿°
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ
  • extralobar pulmonary sequestration
    ¿±¿ÜÇãÆÄºÐ¸®Áõ, ¿±¿ÜÆóºÐ¸®Áõ
  • hypertrophic pulmonary osteoarthropathy
    ºñ´ë¼ºÆó»À°üÀýº´(Áõ)
  • high altitude pulmonary edema
    °íÁö´ëÆóºÎÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • interstitial salpingitis
    »çÀÌÁúÀڱðü¿°
  • interstitial tissue
    »çÀÌÁúÁ¶Á÷, °£ÁúÁ¶Á÷
  • interstitial fluid pressure
    °£Áú¾×¾Ð·Â
  • luetic interstitial keratitis
    ¸Åµ¶»çÀÌÁú°¢¸·¿°
  • progressive hypertrophic interstitial neuritis
    ÁøÇàºñ´ë»çÀÌÁú½Å°æ¿°
  • plexogenic pulmonary arteriopathy
    ¾ó±âÇü¼ºÆóµ¿¸Æº´Áõ
  • pulmonary actinomycosis
    ÇãÆÄ¹ÙÄû»ì±ÕÁõ, Æó¹æ¼±±ÕÁõ
  • pulmonary alveolus
    ÇãÆÄ²Ê¸®, ÆóÆ÷
  • pulmonary arch
    ÇãÆÄµ¿¸ÆÈ°
  • pulmonary arteriosclerosis
    Æóµ¿¸Æ°æÈ­Áõ
  • pulmonary artery
    ÇãÆÄµ¿¸Æ, Æóµ¿¸Æ
  • pulmonary blastomycosis
    Æóºí¶ó½ºÅä¹Ì¼¼½ºÁ¾
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ, ¸¸¼ºÆó¼âÆóº´
  • pulmonary compliance
    ÇãÆÄź¼º, Æóź¼º, ÇãÆÄÀ¯¼øµµ
  • pulmonary diffusing capacity
    ÆóÈ®»ê´É·Â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary pulmonary lobule
    ÀÏÂ÷ÇãÆÄ¼Ò¿±
  • proteinosis, pulmonary alveolar
    ´Ü¹é(Áú)Áõ(Ó±ÛÜ(òõ)ñø), ÆóÆ÷¼º(øËøààõ)
  • pulmonary
    ÆóÀÇ
  • pulmonary
    ÆóÀÇ(øË¡­)
  • pulmonary P
    Æó¼ºP ½ÉÀüµµ¿ë¾î .
  • pulmonary T
    Æó¼ºT ½ÉÀüµµ¿ë¾î .
  • pulmonary abscess
    Æó³ó¾ç(øËÒÛåË).
  • pulmonary acariasis
    ȸÃþÁõ(ȸÃþ¡­ñø)
  • pulmonary actinomycosis
    Æó¹æ¼±±ÕÁõ(øËÛ¯àÊжñø).
  • pulmonary alveolar microlithiasis
    ÆóÆ÷¹Ì¼®Áõ(øËøàÚ°à´ñø).
  • pulmonary alveolar microlithiasis
    ÆóÆ÷¹Ì¼®Áõ(øËøàÚ°à´ñø)
  • pulmonary alveolar proteinosis
    ÆóÆ÷´Ü¹éÁõ(øËøàÓ±ÛÜñø).
  • pulmonary alveolar proteinosis
    ÆóÆ÷´Ü¹éÁõ(øËøàÓ±ÛÜñø)
  • pulmonary alveolar proteinosis
    ÆóÆ÷´Ü¹éÁõ(øËøàÓ±ÛÜñø)
  • pulmonary alveolar tree
    ÇãÆÄ²Ê¸®¼ÛÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • degenerative diffuse cerebral sclerosis
    ÅðÇ༺ ¹Ì¸¸¼º ³ú°æÈ­(Áõ)(¡­Ú¯Ø·àõ ÒàÌãûùñø).
  • diffuse
    ¹Ì¸¸¼º, »êÀ缺
  • diffuse abscess
    ¹Ì¸¸¼º ³ó¾ç(¡­³ó¾ç).
  • diffuse alveolar damage
    ¹Ì¸¸¼ºÆóÆ÷¼Õ»ó(¡­øËøàáßß¿)
  • diffuse and macular atrophic dermatosis
    ±¤¹üÀ§ ¹Ý¼º À§Ãà ÇǺκ´
  • diffuse aneurysm =consecutive a
    ±¤¹üÀ§µ¿¸Æ·ù(ÎÆÛôêÌÔÑØæ×»).
  • diffuse aneurysm =consecutive a.
    ±¤¹üÀ§µ¿¸Æ·ù(±¤¹üÀ§µ¿¸Æ·ù).
  • diffuse arteriosclerosis
    ¹Ì¸¸¼º µ¿¸Æ°æÈ­Áõ(گؼàõÔÑØæÌãûùñø).
  • diffuse atelectasis
    ¹Ì¸¸¼º ¹«±âÆó.
  • diffuse atrophy of alveolar bone
    ¹Ì¸¸¼º Ä¡Á¶°ñÀ§Ãà(¡­öÍðËÍéê×õê).
  • diffuse axonal injury
    ¹Ì¸¸¼º Ãà»è¼Õ»ó
  • diffuse bronchiolitis
    ¹Ì¸¸¼º ¼¼±â°üÁö¿°.
  • diffuse cerebral atrophy
    ¹Ì¸¸¼º ³úÀ§Ãà.
  • diffuse cerebral sclerosis
    ¹Ì¸¸¼º ³ú°æÈ­Áõ.
  • diffuse collagen disease
    ¹Ì¸¸¼º ±³¿øº´.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • restrictive pulmonary disease
    ±¸¼Ó¼ºÆóÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
PC avoirdupois weight [Lat. pondus civile]; packed cells; paper chromatography; paracortex; parent cell...
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
PPA palpation, percussion, auscultation; pepsin A; phenylpropanolamine; phenylpyruvic acid; Pittsburgh p...
DOPS diffuse obstructive pulmonary syndrome; dihydroxyphenylserine
DPD Department of Public Dispensary; depression pure disease; desoxypyridoxine; diffuse pulmonary diseas...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
PPF periportal fibrosis
SHF schistosomal hepatic fibrosis
DLCL B-diffuse large-cell lymphomas
D Diffuse
DHL Diffuse 'histiocytic' lymphoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pulmonary artery
    Æä µ¿¸Æ
    ¿Â¸ö¿¡¼­ ½ÉÀåÀ¸·Î µ¹¾Æ¿Â Á¤¸ÆÇ÷À» Æó·Î º¸³»´Â Ç÷°ü. »ç¶÷ÀÇ ¸ö¿¡¼­´Â ¿ì½É½Ç¿¡¼­ ³ª¿À´Â Ç÷°üÀÌ Æóµ¿¸ÆÀ¸·Î¼­ ´ëµ¿¸ÆÀÇ ¾ÕÀ» ºñ½ºµëÈ÷ »óÁÂÈĹæÀ¸·Î ¹ù¾î ´ëµ¿¸Æ±ÃÀÇ ¾Æ·¡¿¡¼­ Á¿ìÀÇ Æóµ¿¸Æ
  • pulmonary artery banding
    Æóµ¿¸Æ ¹êµù
    ½ÉÀå ¼ö¼úÀ» óÀ½ºÎÅÍ ¿ÏÀüÈ÷ ±³Á¤ÇØÁÖ´Â ¿ÏÀü ±³Á¤¼ú°ú 1Â÷·Î °í½ÄÀû
  • pulmonary artery pressure
    Æó µ¿¸Æ¾Ð
  • pulmonary atelectasis
    ¹«±âÆó
  • pulmonary atresia
    Æóµ¿¸ÆÆÇ Æó¼â, Æóµ¿¸ÆÆÇ Æó¼âÁõ
    ¿ì½É½Ç¿¡¼­ ±â½ÃÇÏ´Â Æó µ¿¸ÆÀÌ ¿ÏÀüÈ÷ ´ÜÀýµÇ¾î Ç÷·ù°¡ ³ª°¥ ¼ö ¾ø´Â »óŸ¦ ¸»ÇÑ´Ù. ½É½Ç Áß°Ý °á¼ÕÁõÀÌ ÀÖÀ» ¼öµµ ÀÖ°í ¾øÀ» ¼öµµ Àִµ¥ ½É½Ç Áß°Ý °á¼ÕÁõÀÌ ¾øÀ» °æ¿ì´Â ¿ì½É½Ç¿¡ Ç÷·ùÀÇ ºÎÇϰ¡ ³Ê¹« ¸¹ÀÌ °É·Á ž Á÷ÈĺÎÅÍ º¹ÀâÇÑ º´¸®¸¦ ³ªÅ¸³»¸ç ½ÉÇÑ Áõ¼¼¸¦ º¸ÀδÙ. À̶§´Â ¶ÇÇÑ ½É¹æ Áß°Ý °á¼ÕÁõÀÌ ÀÖ¾î¾ß »ýÁ¸ÇÒ ¼ö ÀÖ´Ù. ½É½Ç Áß°Ý °á¼ÕÀÌ ¾ø´Â Æóµ¿¸ÆÀÇ Æó¼â´Â ¿ì½É½ÇÀÇ ºñ´ë´Â ¹°·Ð ¿ì½É½Ç¿¡¼­ °ü»ó µ¿¸ÆÀ¸·Î Ç÷·ù°¡ È帣´Â µî º¹ÀâÇÑ º´¸®°¡ ÀÖ´Ù. ±×¸®°í Æóµ¿¸Æ Æó¼â·Î ÀÎÇØ Æóµ¿¸ÆÀ¸·Î °¡´Â Ç÷·ù´Â ´ëµ¿¸Æ¿¡¼­ ±â½ÃÇØ¾ß Çϴµ¥ ÀÌ ¶ÇÇÑ ¸Å¿ì º¹ÀâÇÑ °æ·Î¸¦ ÅëÇØ ¿¬°áµÈ´Ù. ´Ü¼øÈ÷ Æóµ¿¸ÆÆÇ¸·¸¸ Æó¼âµÇ¾úÀ» °æ¿ì¿¡´Â µ¿¸Æ°ü °³Á¸ÁõÀ» ÅëÇØ Ç÷·ù°¡ À¯ÁöµÇ´Â °æ¿ì°¡ ¸¹Áö¸¸ ±×·¸Áö ¾Ê´Â °æ¿ì ´ëµ¿¸ÆÀÇ ¿©·¯ ±ºµ¥¿¡¼­ °¢°¢ µû·Îµû·Î Ç÷·ù°¡ ³ª¿Í ¼ö¼úÀ» ¸Å¿ì ¾î·Æ°Ô ¸¸µé ¼öµµ ÀÖ´Ù. ¼±Ãµ¼º û»öÁõÇü ½ÉÀ庴 Áß¿¡¼­µµ ¾î·Á¿î ¼ö¼ú ÁßÀÇ ÇϳªÀÌ´Ù. º´º¯ÀÌ º¹ÀâÇØ¼­ ÀÏ¹Ý ½ÉÀå ¼ö¼ú·Î ±³Á¤ÀÌ ºÒ°¡´ÉÇÒ ¶§´Â ½ÉÀå Æó µ¿½Ã À̽ÄÀ» ÇØÁÖ¾î¾ß ÇÑ´Ù.
  • pulmonary capillary wedge pressure
    Æó¸ð¼¼Ç÷°ü ½û±â¾Ð
  • pulmonary collapse
    Æó ÇãÅ»
  • pulmonary cyanosis
    Æó¼º û»öÁõ
    Æó Ç÷¾×ÀÇ »ê¼Ò Æ÷È­ °áÇÌ¿¡ ÀÇÇÑ ÁßÃß¼º û»öÁõ.
  • pulmonary edema
    Æó ºÎÁ¾, Æó ¼öÁ¾
    ÆóÆ÷¿Í ¼¼±â°üÁö ³»¿¡ ¾×ü°¡ Âù »óÅÂ.
  • pulmonary emphysema
    Æó ±âÁ¾
    ÆóÆ÷°¡ ÇöÀúÇÏ°Ô È®ÀåÇÏ¿© ÆóÆ÷ ³»ÀÇ ÇԱⷮÀÌ Áõ°¡ÇÑ »óÅÂ. ¿©·¯ °¡Áö ¿øÀÎÀ¸·Î ÀϾÁö¸¸, °¡Àå º¸ÆíÀûÀ¸·Î º¼ ¼ö ÀÖ´Â °ÍÀº ³ëÀμº Æó±âÁ¾ÀÌ´Ù. ±× ¹Û¿¡ ±â°üÁö õ½Ä, ¸¸¼º ±â°üÁö¿° µîÀ¸·Î ÀϾ´Ù. Á÷¾÷º´À¸·Î¼­´Â ÃëÁ־DZâÀÇ ¿¬ÁÖÀÚ µî¿¡¼­µµ º¼ ¼ö ÀÖ´Ù. È£Èí °ï¶õ, ±âħ µîÀÇ Áõ¼¼¸¦ ³ªÅ¸³»¸ç, õ½Ä°ú ºñ½ÁÇÑ È£Èí °ï¶õµµ º¸ÀδÙ. ÁßÁõÀÎ °æ¿ì´Â ½ÉÀå¿¡ ºÎ´ãÀ» ÁÖ¾î Æó¼º ½ÉÀ¸·Î ÁøÇàÇÏ¿© ºÎÁ¾, Ä¡¾Æ³ëÁ¦°¡ ³ªÅ¸³­´Ù. ÈäºÎ X¼± »çÁø¿¡¼­´Â Æó¾ß°¡ ¹à°Ô ³ªÅ¸³ª°í, Ⱦ°Ý¸·ÀÌ Á¤»óº¸´Ù ³·Àº À§Ä¡¿¡ ÀÖ´Ù. Ä¡·á·Î¼­´Â ±â°üÁö È®ÀåÁ¦, ºÎ½Å ÇÇÁú È£¸£¸óÀÇ Åõ¿©°¡ À¯È¿ÇÏ´Ù. ÁßÁõÀÎ °æ¿ì´Â °­½ÉÁ¦¿Í ÀÌ´¢Á¦ÀÇ Åõ¿©³ª »ê¼Ò ÈíÀÔÀ» ÇÊ¿ä·Î ÇÑ´Ù.
  • pulmonary failure
    Æó ºÎÀü
  • pulmonary function
    Æó ±â´É
  • pulmonary hamartoma
    Æó °ú¿ÀÁ¾
  • pulmonary hemorrhage
    Æó ÃâÇ÷
  • pulmonary hypertension
    Æó ¼øÈ¯ ½Â¾Ð, Æó °íÇ÷¾ÐÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
diffuse small cleaved cell lymphoma <tumour> A diffuse poorly differentiated lymphocytic lymphoma; follicular centre cell lymphoma that lacks a follicular pattern; malignancy is of intermediate grade.
(05 Mar 2000)
diffuse waxy spleen A condition of amyloid degeneration of the spleen, affecting chiefly the extrasinusoidal tissue spaces of the pulp.
Synonym: lardaceous spleen
(05 Mar 2000)
oesophageal spasm, diffuse A motor disorder of the oesophagus characterised by chest pain and dysphagia. Pathogenesis is unclear. Strong, nonpropulsive contractions of the oesophagus evoked by deglutition occur, especially in the elderly.
(12 Dec 1998)
keratoderma, palmoplantar, diffuse An autosomal dominant disorder characterised by a widely distributed, well-demarcated hyperkeratosis of the palms and soles. There is more than one genotypically distinct form, each of which is clinically similar but histologically distinguishable. Diffuse palmoplantar keratoderma is distinct from palmoplantar keratoderma (keratoderma, palmoplantar), as the former exhibits autosomal dominant inheritance and hyperhidrosis is frequently present.
(12 Dec 1998)
leishmaniasis, diffuse cutaneous A form of leishmaniasis, cutaneous caused by leishmania aethiopica in ethiopia and kenya, l. Pifanoi in venezuela, l. Braziliensis in south america, and l. Mexicana in central america. This disease is characterised by massive dissemination of skin lesions without visceral involvement.
(12 Dec 1998)
leukodystrophy with diffuse Rosenthal fibre formation A metabolic disorder whose onset can be in infancy, adolescence, or adulthood; characterised pathologically by widespread cerebral demyelination with astrocyte and primitive oligodendroglial cell proliferation; refractile Rosenthal fibres result from the degeneration of these proliferating cells; aetiology unknown, but possibly due to a metabolic defect of astrocytes; sex-linked recessive disorder.
(05 Mar 2000)
lymphoma, diffuse Malignant lymphoma in which neoplastic cells diffusely infiltrate the entire lymph node without any definite organised pattern. Patients whose lymphomas present a diffuse pattern generally have a more unfavorable survival outlook than those presenting with a follicular or nodular pattern.
(12 Dec 1998)
lymphoma, large-cell, diffuse Malignant lymphoma composed of large cells which may be both cleaved and noncleaved. The pattern is predominantly diffuse. most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
(12 Dec 1998)
lymphoma, mixed-cell, diffuse A heterogeneous group of intermediate-grade lymphomas of mixed cellular composition. Although they have not been extensively studied, it appears that they are predominantly B-cell diseases.
(12 Dec 1998)
lymphoma, small cleaved-cell, diffuse An intermediate-grade malignant lymphoma in which the neoplastic cells (B-lymphocytes) exhibit variability in size, configuration, and degree of differentiation. The cells have distinctive nuclei, irregular in shape, with marked indentations and angularity.
(12 Dec 1998)
acute interstitial nephritis <nephrology> A relatively uncommon condition which is characterised by inflammation of the renal tubules, glomeruli and surrounding tissue. Interstitial nephritis is usually be temporary and often associated with the use of a particular medication. Chronic and progressive forms do exist.
Drugs that have been associated with interstitial nephritis include penicillins, ampicillin, sulpha drugs, non-steroidal anti-inflammatory agents, furosemide and thiazide diuretics. May result in mild kidney dysfunction or acute renal failure. Treatment may be with corticosteroids.
Incidence: 1 in 25,000.
(29 Dec 1997)
acute interstitial pneumonia A severe and usually fatal form of pneumonia occurring primarily in infants usually considered a form of hypersensitivity pneumonitis.
(05 Mar 2000)
acute interstitial pneumonitis Usually considered a form of hypersensitivity pneumonitis.
(05 Mar 2000)
apical interstitial lung disease <radiology> A radiological diagnosis where fibrosis is seen in the apices (upper sections) of the lungs.
Likely causes include: cystic fibrosis, ankylosing spondylitis, sarcoidosis, silicosis, eosinophlic granuloma, TB and fungus, particularly aspergillus infection.
(25 Jun 1999)
basilar interstitial lung disease <radiology> B bronchiectasis, A asbestosis, D drugs / DIP, L lymphangitic metastasis / LAM, A aspiration, S sarcoidosis, S scleroderma
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á